SCROLL DOWN

Tuberculosis (TB) is the Leading Cause of Death from a Single Infectious Agent in the World.1

Innovative Research & Development

Otsuka searches for innovative solutions to address gaps in TB treatment.

Responsible Access to Medicines

Otsuka’s working on widening access to a multidrug-resistant TB (MDR-TB) medicine while ensuring antimicrobial stewardship.

Collaboration

Collaboration are essential in the fight against TB.

Curbing Drug Resistance

Otsuka’s anti-microbial resistance task force works to curb resistance to antibiotics used in MDR-TB treatment.

References

1. World Health Organization. Global Tuberculosis Report 2020. World Health Organization, Geneva, 2020.

Information current as of 30-12-2020
Reference ONP-COP-2000001

Discover Otsuka